Table 3 Laboratory characteristics of participants with GDM vs. controls
From: The risk of metabolic syndrome after gestational diabetes mellitus – a hospital-based cohort study
GDM | Control | p value | |
|---|---|---|---|
(n = 119) | (n = 120) | ||
Leucocytes, 109/L | 5.8 ± 1.6 | 5.2 ± 1.4 | 0.008 |
Haemoglobin, g/L | 133.2 ± 9.3 | 128.6 ± 12.9 | 0.001 |
Platelets, 109/L | 241.9 ± 58.2 | 244.0 ± 52.5 | NS |
ALAT, U/L | 22.8 ± 17.4 | 19.7 ± 10.5 | NS |
Creatinine, umol/L | 66.6 ± 7.7 | 64.5 ± 7.8 | 0.048 |
U-AlbCre, mg/mmol | 0.67 ± 0.5 | 0.57 ± 0.3 | NS (0.070) |
Fibrinogen, g/L | 3.4 ± 0.9 | 3.2 ± 1.0 | NS (0.096) |
Fasting glucose, mmol/L | 5.6 ± 0.6 | 5.3 ± 0.3 | < 0.001 |
Total cholesterol, mmol/L | 4.7 ± 0.9 | 4.6 ± 0.8 | NS |
HDL cholesterol, mmol/L | 1.5 ± 0.3 | 1.6 ± 0.3 | NS |
LDL cholesterol, mmol/L | 3.0 ± 0.7 | 2.8 ± 0.6 | NS |
Triglycerides, mmol/L | 1.1 ± 0.6 | 0.9 ± 0.4 | < 0.001 |